Otviciclib
Otviciclib (Compound 86) is a CDK inhibitor demonstrating potent antiproliferative effects on solid tumor cells such as HCT116, NCIH82, and DU145, while showing minimal toxicity to normal cells. It effectively induces G2/M phase arrest and apoptosis (apoptosis) . Otviciclib exhibits broad-spectrum anticancer activity against cancers like colorectal, pancreatic, and lung cancer.
Product Specifications
CAS Number
2228039-87-8
Smiles
O=C1N=C (NC2=C1C (=NN2C3=C (Cl) C=C (C=C3Cl) S (=O) (=O) N) N (C) C) CC4=CC=C (C=C4) NC (=O) CN (CC) CC
Molecular Formula
C26H30Cl2N8O4S
Molecular Weight
621.54
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1431059-01 0.02 mg (E-Coli)
Recombinant Xenopus laevis cAMP-regulated phosphoprotein 19-B (arpp19-b)
Sign In for Pricing
View Details MBS1431059-02 0.1 mg (E-Coli)
Recombinant Xenopus laevis cAMP-regulated phosphoprotein 19-B (arpp19-b)
Sign In for Pricing
View Details MBS1431059-03 0.02 mg (Yeast)
Recombinant Xenopus laevis cAMP-regulated phosphoprotein 19-B (arpp19-b)
Sign In for Pricing
View Details MBS1431059-04 0.1 mg (Yeast)
Recombinant Xenopus laevis cAMP-regulated phosphoprotein 19-B (arpp19-b)
Sign In for Pricing
View Details MBS1431059-05 0.02 mg (Baculovirus)
Recombinant Xenopus laevis cAMP-regulated phosphoprotein 19-B (arpp19-b)
Sign In for Pricing
View Details MBS1431059-06 1 mg (E-Coli)
Recombinant Xenopus laevis cAMP-regulated phosphoprotein 19-B (arpp19-b)
Sign In for Pricing
View Details